Published in Lancet on November 29, 1997
Direct visualization of mouse brain oxygen distribution by electron paramagnetic resonance imaging: application to focal cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.08
Early computed-tomography abnormalities in acute stroke. Lancet (1998) 0.75
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol (1996) 3.70
Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke (2001) 3.58
The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr (1994) 2.88
Identification by positron emission tomography of neuronal loss in acute vegetative state. Lancet (2000) 2.85
STN-DBS activates the target area in Parkinson disease: an FDG-PET study. Neurology (2008) 2.27
Cerebral representation of one's own past: neural networks involved in autobiographical memory. J Neurosci (1996) 1.97
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet (2001) 1.94
Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain (2001) 1.93
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology (2010) 1.92
Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke (1996) 1.90
Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke (1997) 1.88
Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry (2008) 1.60
11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology (1998) 1.56
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry (1998) 1.55
Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke (1999) 1.55
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology (2005) 1.54
Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. Eur J Neurol (2012) 1.51
Which targets are relevant for therapy of acute ischemic stroke? Stroke (1999) 1.51
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol (1996) 1.49
CT angiography and Doppler sonography for emergency assessment in acute basilar artery ischemia. Stroke (1999) 1.48
Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol (1996) 1.46
Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. J Nucl Med (1991) 1.46
Experimental observation of the topological structure of exceptional points. Phys Rev Lett (2001) 1.44
Haemodilution with dextran 40 and hydroxyethyl starch and its effect on cerebral microcirculation. J Neurol (1989) 1.43
Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke. Arch Neurol (1998) 1.43
Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr (1992) 1.43
Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology (1999) 1.43
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
[FEES in the stroke unit: recommendations for implementation in the clinical routine]. Nervenarzt (2013) 1.42
Performance of a randomization test for single-subject (15)O-water PET activation studies. J Cereb Blood Flow Metab (1997) 1.40
[Clinical features and current treatment of hypertensive crisis]. Dtsch Med Wochenschr (2003) 1.39
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med (1994) 1.38
Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology (2001) 1.37
Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke (1998) 1.34
Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Crit Care Med (1995) 1.33
Normal and pathological aging--findings of positron-emission-tomography. J Neural Transm (Vienna) (1998) 1.33
Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke (1995) 1.30
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis (1998) 1.29
Impaired episodic memory retrieval in a case of probable psychogenic amnesia. Psychiatry Res (1997) 1.29
Stroke following internal carotid artery occlusion - a contra-indication for intravenous thrombolysis? Eur J Neurol (1999) 1.28
Potential of CT angiography in acute ischemic stroke. AJNR Am J Neuroradiol (1997) 1.26
Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang (1998) 1.24
Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol (1983) 1.22
Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia (1994) 1.22
Cortical neuronal function during ischemia. Effects of occlusion of one middle cerebral artery on single-unit activity in cats. Arch Neurol (1976) 1.20
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord (2009) 1.18
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study. Ann Neurol (2001) 1.17
Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry (2002) 1.13
Endovascular therapy of arteriovenous fistulae with electrolytically detachable coils. Neuroradiology (1999) 1.10
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol (2008) 1.10
Vascular dementia: perfusional and metabolic disturbances and effects of therapy. J Neural Transm Suppl (1996) 1.09
An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med (1994) 1.08
Spastic paraplegia associated with Addison's disease: adult variant of adreno-leukodystrophy. J Neurol (1976) 1.07
Evidence of anaphylaxy after alteplase infusion. Stroke (1999) 1.07
Hemorrhagic transformation of cerebral infarction--possible mechanisms. Thromb Haemost (1999) 1.05
Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats: residual perfusion and efficacy of postischemic reperfusion. J Cereb Blood Flow Metab (1997) 1.04
Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke (1999) 1.02
One-year follow-Up in acute stroke patients treated with rtPA in clinical routine. Stroke (2000) 1.01
Early [(11)C]Flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke (2000) 1.01
Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg (1993) 1.01
In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol (1992) 1.00
Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab (1984) 1.00
Quantitative kinetics of [124I]FIAU in cat and man. J Nucl Med (2001) 1.00
Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol (1994) 1.00
Preoperative activation and intraoperative stimulation of language-related areas in patients with glioma. Neurosurgery (1997) 0.99
Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology (1990) 0.99
Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke (1998) 0.99
Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. Stroke (1999) 0.98
Cerebral blood flow and brain stem lesion. Z Neurol (1972) 0.98
Observation of a chiral state in a microwave cavity. Phys Rev Lett (2003) 0.98
Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI. Eur J Radiol (1996) 0.98
Decompressive craniectomy in a rat model of "malignant" cerebral hemispheric stroke: experimental support for an aggressive therapeutic approach. J Neurosurg (1996) 0.97
Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab (1998) 0.97
Alterations of neuropsychological function and cerebral glucose metabolism after cardiac surgery are not related only to intraoperative microembolic events. Stroke (1998) 0.96
Localization of language-related cortex with 15O-labeled water PET in patients with gliomas. Neuroimage (1998) 0.96
Decompressive craniectomy for cerebral infarction. An experimental study in rats. Stroke (1995) 0.96
Vascular MR contrast enhancement in cerebrovascular disease. AJNR Am J Neuroradiol (1996) 0.96
PET-based molecular imaging in neuroscience. Eur J Nucl Med Mol Imaging (2003) 0.95
Infusion of recombinant tissue plasminogen activator for treatment of basilar artery occlusion. Stroke (1990) 0.95
Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Brain Res (1985) 0.95
Regional cerebral blood flow in man at rest and during exercise. J Neurol (1987) 0.95
Cerebral haemorrhage in arteriovenous malformation associated with Klippel-Trenaunay syndrome. J Neurol (1986) 0.94